Related Experiment Video
Updated: Aug 12, 2026
Localization of the Locus Coeruleus in the Mouse Brain
Published on: March 7, 2019
Elevated concentrations of CRF in the locus coeruleus of depressed subjects
Garth Bissette1, Violetta Klimek, Jun Pan
1Division of Neurobiology and Behavioral Research, Department of Psychiatry and Human Behavior, University of Mississippi Medical Center, Jackson, MS 39216, USA. gbissette@psychiatry.umsmed.ed
Abstract:
Research evidence that corticotropin-releasing factor (CRF) plays a role in the pathophysiology of major depressive disorder (MDD) has accumulated over the past 20 years. The elevation of lumbar cerebrospinal fluid (CSF) concentrations of CRF decreased responsiveness of pituitary CRF receptors to challenge with synthetic CRF, and increased levels of serum cortisol in MDD subjects support the hypothesis that CRF is chronically hypersecreted in at least the endocrine circuits of the hypothalamic-pituitary-adrenal (HPA) axis and may also involve other CRF brain circuits mediating emotional responses and/or arousal. One such circuit includes the excitatory CRF input to the locus coeruleus (LC), the major source of norepinephrine in the brain. Furthermore, there are now reports of decreased levels of CRF in lumbar CSF from MDD patients after symptom relief from chronic treatment with antidepressant drugs or electroconvulsive therapy. Whether this normalization reflects therapeutic effects on both endocrine- and limbic-associated CRF circuits has not yet been effectively addressed. In this brief report, we describe increased concentrations of CRF-like immunoreactivity in micropunches of post-mortem LC from subjects with MDD symptoms as established by retrospective psychiatric diagnosis compared to nondepressed subjects matched for age and sex.
Insights
Corticotropin-releasing factor (CRF) is implicated in major depressive disorder (MDD). This study found increased CRF in the locus coeruleus (LC) of individuals with MDD, suggesting a role for CRF in brain circuits affecting mood and arousal.
Area of Science:
- Neuroscience
- Psychiatry
- Endocrinology
Background:
- Accumulating evidence suggests corticotropin-releasing factor (CRF) is involved in major depressive disorder (MDD) pathophysiology.
- Elevated CRF in cerebrospinal fluid (CSF) and increased cortisol levels in MDD support chronic CRF hypersecretion in the hypothalamic-pituitary-adrenal (HPA) axis.
- CRF may also affect brain circuits involved in emotional responses and arousal, including the locus coeruleus (LC).
Purpose of the Study:
- To investigate the role of CRF in the locus coeruleus (LC) in major depressive disorder (MDD).
- To examine post-mortem LC tissue for CRF-like immunoreactivity in individuals diagnosed with MDD.
Main Methods:
- Analysis of post-mortem brain tissue samples from the locus coeruleus (LC).
- Utilized micropunch technique to isolate specific brain regions.
- Measured CRF-like immunoreactivity using established laboratory methods.
- Compared immunoreactivity levels between subjects with MDD and age/sex-matched non-depressed controls.
Main Results:
- Significantly increased concentrations of CRF-like immunoreactivity were observed in the locus coeruleus (LC) of subjects with MDD.
- Findings suggest altered CRF signaling within the LC in the context of major depressive disorder.
Conclusions:
- The study provides evidence for increased CRF in the locus coeruleus (LC) in major depressive disorder (MDD).
- This finding supports the hypothesis that CRF dysregulation in specific brain circuits contributes to the pathophysiology of MDD.
- Further research is needed to understand the therapeutic implications of these findings.
